Literature DB >> 25112808

Identification of drug-resistant subpopulations in canine hemangiosarcoma.

A Khammanivong1, B H Gorden1, A M Frantz1, A J Graef1, E B Dickerson1,2.   

Abstract

Canine hemangiosarcoma is a rapidly progressive disease that is poorly responsive to conventional chemotherapy. Despite numerous attempts to advance treatment options and improve outcomes, drug resistance remains a hurdle to successful therapy. To address this problem, we used recently characterized progenitor cell populations derived from canine hemangiosarcoma cell lines and grown as non-adherent spheres to identify potential drug resistance mechanisms as well as drug-resistant cell populations. Cells from sphere-forming cultures displayed enhanced resistance to chemotherapy drugs, expansion of dye-excluding side populations and altered ATP-binding cassette (ABC) transporter expression. Invasion studies demonstrated variability between cell lines as well as between sphere and monolayer cell populations. Collectively, our results suggest that sphere cell populations contain distinct subpopulations of drug-resistant cells that utilize multiple mechanisms to evade cytotoxic drugs. Our approach represents a new tool for the study of drug resistance in hemangiosarcoma, which could alter approaches for treating this disease.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  ABC transporter; canine; drug resistance; hemangiosarcoma; side population

Mesh:

Year:  2014        PMID: 25112808      PMCID: PMC5712213          DOI: 10.1111/vco.12114

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  42 in total

Review 1.  Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.

Authors:  Thomas Brabletz; Andreas Jung; Simone Spaderna; Falk Hlubek; Thomas Kirchner
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

2.  Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity.

Authors:  Gong Zhang; Lei Ma; You-Ke Xie; Xiao-Bo Miao; Chuan Jin
Journal:  Mol Med Rep       Date:  2012-06-08       Impact factor: 2.952

3.  Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.

Authors:  Lance W U'Ren; Barbara J Biller; Robyn E Elmslie; Douglas H Thamm; Steven W Dow
Journal:  J Vet Intern Med       Date:  2007 Jan-Feb       Impact factor: 3.333

4.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9.

Authors:  Andrei V Krivtsov; David Twomey; Zhaohui Feng; Matthew C Stubbs; Yingzi Wang; Joerg Faber; Jason E Levine; Jing Wang; William C Hahn; D Gary Gilliland; Todd R Golub; Scott A Armstrong
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

5.  Identification of three molecular and functional subtypes in canine hemangiosarcoma through gene expression profiling and progenitor cell characterization.

Authors:  Brandi H Gorden; Jong-Hyuk Kim; Aaron L Sarver; Aric M Frantz; Matthew Breen; Kerstin Lindblad-Toh; Timothy D O'Brien; Leslie C Sharkey; Jaime F Modiano; Erin B Dickerson
Journal:  Am J Pathol       Date:  2014-02-11       Impact factor: 4.307

6.  Predicting drug sensitivity and resistance: profiling ABC transporter genes in cancer cells.

Authors:  Gergely Szakács; Jean-Philippe Annereau; Samir Lababidi; Uma Shankavaram; Angela Arciello; Kimberly J Bussey; William Reinhold; Yanping Guo; Gary D Kruh; Mark Reimers; John N Weinstein; Michael M Gottesman
Journal:  Cancer Cell       Date:  2004-08       Impact factor: 31.743

Review 7.  ABC multidrug transporters: structure, function and role in chemoresistance.

Authors:  Frances J Sharom
Journal:  Pharmacogenomics       Date:  2008-01       Impact factor: 2.533

8.  Side population does not define stem cell-like cancer cells in the adrenocortical carcinoma cell line NCI h295R.

Authors:  Urs D Lichtenauer; Igor Shapiro; Klaus Geiger; Marcus Quinkler; Martin Fassnacht; Roland Nitschke; Klaus-Dieter Rückauer; Felix Beuschlein
Journal:  Endocrinology       Date:  2007-12-06       Impact factor: 4.736

9.  Identification and characterization of ovarian cancer-initiating cells from primary human tumors.

Authors:  Shu Zhang; Curt Balch; Michael W Chan; Hung-Cheng Lai; Daniela Matei; Jeanne M Schilder; Pearlly S Yan; Tim H-M Huang; Kenneth P Nephew
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

10.  S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma.

Authors:  Ali Khammanivong; Chengxing Wang; Brent S Sorenson; Karen F Ross; Mark C Herzberg
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more
  5 in total

1.  Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancers.

Authors:  J-H Kim; A M Frantz; A L Sarver; B H Gorden Klukas; M Lewellen; T D O'Brien; E B Dickerson; J F Modiano
Journal:  Vet Comp Oncol       Date:  2017-11-20       Impact factor: 2.613

2.  A double blinded, placebo-controlled pilot study to examine reduction of CD34 +/CD117 +/CD133 + lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma.

Authors:  Daisuke Ito; Michael Childress; Nicola Mason; Amber Winter; Timothy O'Brien; Michael Henson; Antonella Borgatti; Mitzi Lewellen; Erika Krick; Jane Stewart; Sarah Lahrman; Bartek Rajwa; Milcah C Scott; Davis Seelig; Joseph Koopmeiners; Stephan Ruetz; Jaime Modiano
Journal:  F1000Res       Date:  2015-02-11

3.  Enrichment of the embryonic stem cell reprogramming factors Oct4, Nanog, Myc, and Sox2 in benign and malignant vascular tumors.

Authors:  Clarissa N Amaya; Brad A Bryan
Journal:  BMC Clin Pathol       Date:  2015-09-26

Review 4.  Pathobiology of Hemangiosarcoma in Dogs: Research Advances and Future Perspectives.

Authors:  Jong-Hyuk Kim; Ashley J Graef; Erin B Dickerson; Jaime F Modiano
Journal:  Vet Sci       Date:  2015-11-06

5.  Evaluation of an autologous cancer vaccine for the treatment of metastatic canine hemangiosarcoma: a preliminary study.

Authors:  Michael D Lucroy; Ryan M Clauson; Mark A Suckow; Ferris El-Tayyeb; Ashley Kalinauskas
Journal:  BMC Vet Res       Date:  2020-11-18       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.